Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply

N Kimer; A Krag; Lise Lotte Gluud

doi:10.1111/apt.12904

Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply

1 Citation (Scopus)

Original language	English
Journal	Alimentary Pharmacology and Therapeutics
Volume	40
Issue number	7
Pages (from-to)	858-9
Number of pages	2
ISSN	0269-2813
DOIs	https://doi.org/10.1111/apt.12904
Publication status	Published - Oct 2014

Keywords

Hepatic Encephalopathy
Humans
Protective Agents
Rifamycins

Access to Document

10.1111/apt.12904

Cite this

@article{7d750e743a9b43798990d471d5cc2fe7,

title = "Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply",

keywords = "Hepatic Encephalopathy, Humans, Protective Agents, Rifamycins",

author = "N Kimer and A Krag and Gluud, \{Lise Lotte\}",

year = "2014",

month = oct,

doi = "10.1111/apt.12904",

language = "English",

volume = "40",

pages = "858--9",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Letter

T2 - the effects of rifaximin in hepatic encephalopathy--authors' reply

AU - Kimer, N

AU - Krag, A

AU - Gluud, Lise Lotte

PY - 2014/10

Y1 - 2014/10

KW - Hepatic Encephalopathy

KW - Humans

KW - Protective Agents

KW - Rifamycins

UR - https://www.scopus.com/pages/publications/84908117034

U2 - 10.1111/apt.12904

DO - 10.1111/apt.12904

M3 - Comment/debate

C2 - 25185737

SN - 0269-2813

VL - 40

SP - 858

EP - 859

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 7

ER -

Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply

Keywords

Access to Document

Other files and links

Cite this